Delivra Health Brands Inc. (DHB.V)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 876 Thousand CAD | 576.09% |
| 2022 | -184 Thousand CAD | 97.37% |
| 2021 | -7 Million CAD | 75.44% |
| 2020 | -28.53 Million CAD | 64.26% |
| 2019 | -79.85 Million CAD | -186.72% |
| 2018 | -27.85 Million CAD | -120.93% |
| 2017 | -12.6 Million CAD | -49.4% |
| 2016 | -8.43 Million CAD | -18143.63% |
| 2015 | -46.25 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | -282 Thousand CAD | 56.55% |
| 2023 Q4 | 1.57 Million CAD | 659.57% |
| 2023 Q2 | -649 Thousand CAD | -387.17% |
| 2023 Q1 | 226 Thousand CAD | 3866.67% |
| 2022 Q3 | -685 Thousand CAD | -176.97% |
| 2022 Q4 | -6000.00 CAD | 99.12% |
| 2022 Q2 | 890 Thousand CAD | 333.6% |
| 2022 FY | -184 Thousand CAD | 97.37% |
| 2022 Q1 | -381 Thousand CAD | 83.06% |
| 2021 Q1 | -1.45 Million CAD | 0.0% |
| 2021 FY | -7 Million CAD | 75.44% |
| 2021 Q4 | -2.24 Million CAD | -34.11% |
| 2021 Q3 | -1.67 Million CAD | -2.88% |
| 2021 Q2 | -1.63 Million CAD | -12.1% |
| 2020 FY | -28.53 Million CAD | 64.26% |
| 2019 FY | -79.85 Million CAD | -186.72% |
| 2018 FY | -27.85 Million CAD | -120.93% |
| 2017 FY | -12.6 Million CAD | -49.4% |
| 2016 FY | -8.43 Million CAD | -18143.63% |
| 2015 FY | -46.25 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.96 Million CAD | 129.547% |
| CanadaBis Capital Inc. | 4.44 Million CAD | 80.29% |
| Decibel Cannabis Company Inc. | -1.77 Million CAD | 149.492% |
| Entourage Health Corp. | -46.16 Million CAD | 101.897% |
| Lifeist Wellness Inc. | -14.12 Million CAD | 106.201% |
| Cannara Biotech Inc. | 6.94 Million CAD | 87.387% |
| Medicure Inc. | -922 Thousand CAD | 195.011% |
| PharmaCielo Ltd. | -16.29 Million CAD | 105.375% |
| Rubicon Organics Inc. | -1.82 Million CAD | 148.039% |
| BioSyent Inc. | 6.46 Million CAD | 86.44% |
| Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | 162.595% |